Annual General Meeting of May 3, 2022 Approval of the financial statements for the fiscal year 2021Distribution of a cash dividend of €3.33 per share and a dividend in kind of EUROAPI shares, at a ratio of one (1) EUROAPI share per twenty-three (23) Sanofi shares, with payment as of May 10, 2022Board compo.
Annual General Meeting of May 3, 2022 Approval of the financial statements for the fiscal year 2021Distribution of a cash dividend of €3.33 per share and a dividend in kind of EUROAPI shares
Sanofi: Annual General Meeting of April 30, 2021
30
Dividend of €3.20 per share payable as of May 7, 2021
Board composition: renewals, ratification of a co-opting Director and appointment of one new Director
Paris, France - April
1 - The Combined General Shareholders Meeting of Sanofi was held on April 30, 2021, without the physical presence of its shareholders, in accordance with the derogating measures adapting the rules governing the deliberation of general meetings taken by the French authorities as part of the fight against COVID-19, at the Company s registered office in Paris, under the chairmanship of Serge Weinberg. All resolutions submitted to the vote were adopted by the shareholders.
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;